CCSD code 0186U: Red cell antigen genotyping (FUT2)

Key Takeaways

CCSD code 0186U is a Proprietary Laboratory Analyses (PLA) code for red cell antigen (H blood group) genotyping, covering gene analysis of FUT2 (fucosyltransferase 2) exon 2.

The test reports the FUT2 variants that determine secretor status – whether a patient expresses ABH blood group antigens in secretions and on tissues – which supports blood typing when standard serology cannot give a clear answer.

0186U maps to one specific proprietary test, Navigator FUT2 Sequencing from Grifols Immunohematology Center, so it cannot be swapped for a generic molecular pathology code and payer recognition must be confirmed before billing.

Practice management software like Pabau helps UK private practices manage CCSD code billing workflows, reducing manual lookup errors and supporting accurate insurer claim submission.

When a patient has been transfused recently or carries a red cell autoantibody, standard blood typing can stop giving clear answers – and that is exactly where DNA-based red cell antigen genotyping earns its place. CCSD code 0186U sits in that specialist corner of the lab schedule: Proprietary Laboratory Analyses, where a single code maps to a single proprietary test and payer coverage is anything but automatic.

UK private practices billing for red cell antigen genotyping need to know not just what the code describes, but which insurers recognise it, what diagnosis codes establish medical necessity, and how to structure the claim so it clears the first time. This reference covers the official descriptor for CCSD code 0186U, what the FUT2 test actually measures, the clinical scenarios where it is ordered, the diagnosis codes that support it, and how to handle reimbursement in UK private healthcare billing.

CCSD code 0186U: Definition and clinical overview

CCSD code 0186U is a Proprietary Laboratory Analyses (PLA) code – a category the American Medical Association (AMA) uses for tests tied to a single laboratory and a single proprietary method. The CCSD (Clinical Coding and Schedule Development) organisation maintains the coding schedule that UK private insurers use, and specialist molecular tests like this one are billed against that schedule in private practice. In plain terms, 0186U covers a genetic test that reads part of the FUT2 gene to help determine a patient’s H blood group and secretor status.

PLA codes like 0186U are tied to a specific proprietary test and the laboratory that developed it. They cannot be used interchangeably with generic molecular pathology codes, and insurer recognition has to be confirmed before the claim goes out.

CPT code 0186U: Official long descriptor

The American Medical Association defines the official descriptor for CPT code 0186U as: Red cell antigen (H blood group) genotyping (FUT2), gene analysis, FUT2 (fucosyltransferase 2) exon 2.

Every element of that descriptor carries billing weight. Breaking it down shows exactly when the code applies and what the pathology report has to support.

Documentation submitted with the claim has to match the descriptor. A report describing serologic (antibody-based) typing only, or analysis of a different gene such as FUT1, would not support a 0186U claim. Practitioners moving from the NHS to private work often meet this level of specificity for the first time – the transition from NHS to private practice billing demands more granular clinical documentation than NHS coding.

Clinical application: Red cell antigen genotyping and secretor status

Blood typing is usually done with serology – mixing a patient’s red cells and plasma with known antisera and reading the reactions. That works well most of the time. It breaks down in specific situations: When a patient has been transfused in the last three months and donor cells are still circulating, when a warm autoantibody coats the red cells, or when reliable typing reagents simply do not exist for a rare antigen. In those cases, reading the gene is more dependable than reading the cell.

This is where FUT2 comes in. The H antigen is the foundation the A and B antigens are built on, and two genes control its expression. FUT1 drives H antigen expression on red cells, while FUT2 – the gene 0186U analyses – drives expression in secretions and on epithelial tissue. People with a working FUT2 gene are “secretors”: They release soluble ABH antigens into saliva and other body fluids, while people with two non-functional copies are “non-secretors”. Genotyping FUT2 exon 2 identifies which variants a patient carries, which helps resolve unusual ABO/H typing results and characterise rare phenotypes such as Bombay and para-Bombay.

• Ordered when: Serologic typing is unreliable – for example, after recent transfusion, with autoimmune haemolytic anaemia, or when antisera for a target antigen are unavailable
• Sample type: A patient blood sample for DNA extraction, since genotyping reads the gene rather than the antigen on the cell
• Output: The FUT2 genotype and predicted secretor status, interpreted alongside the wider red cell antigen work-up
• Clinical relevance: Supports accurate blood group determination for transfusion planning and helps explain ABO/H discrepancies that serology alone cannot

Because 0186U is a single-gene, single-exon test, it is usually one part of a broader immunohematology work-up rather than a stand-alone answer. The claim narrative should record why serologic typing was insufficient and why genotyping was clinically necessary – insurers reviewing prior authorisation for specialist molecular tests will expect that reasoning.

0186U billing and reimbursement

Reimbursement for 0186U varies by payer. In US Medicare billing, PLA codes fall under the Clinical Laboratory Fee Schedule (CLFS) rather than the Physician Fee Schedule, and 0186U was crosswalked to CPT 81403 for gap-fill pricing, with a national limitation amount of around $185.20. In UK private healthcare there is no single fee – each insurer sets its own coverage policy for proprietary molecular tests.

Before billing CCSD code 0186U in any private practice setting, confirm the following with the relevant insurer.

Fee schedule amounts for PLA codes change annually. Always check the current year’s CLFS (for US Medicare) or the insurer’s published schedule before billing. The Bupa procedure code fee schedule guide is a useful reference for UK private practices working through Bupa’s reimbursement structure. Quoting a fixed fee here would be misleading – the only reliable figure is the payer’s own current schedule.

Applicable ICD-10 diagnosis codes for 0186U

Claims for 0186U should be paired with ICD-10 diagnosis codes that establish why DNA-based blood typing was necessary. The diagnosis pointer needs to reflect the clinical scenario – a situation where serologic typing was inconclusive or an extended red cell antigen work-up was clinically indicated – not simply a routine blood test.

The codes above illustrate the kinds of clinical scenarios that support red cell antigen genotyping – they are a starting point, not a guaranteed coverage list. Important: Payer-specific policies may restrict cover to particular diagnosis codes or require additional secondary codes, so always verify the insurer’s current medical-necessity list before finalising the claim. Coders relying on claims management software can use built-in diagnosis code validation to flag mismatches before submission.

How CCSD codes work in UK private healthcare billing

The CCSD system is the standard coding framework for private healthcare billing in the UK. Maintained by the CCSD organisation’s technical guide, the schedule assigns codes to procedures, investigations, and consultations used by private hospitals, independent clinics, and insurers including Bupa, AXA Health, Aviva, Vitality, and WPA.

CCSD codes are structured differently from NHS OPCS-4 procedure codes. Practitioners moving from the NHS to private practice often encounter CCSD billing requirements for the first time and need to understand how the submission process works.

• Code format: Standard CCSD codes use their own alphanumeric format, while 0186U is a CPT-derived Proprietary Laboratory Analyses reference used for a proprietary molecular test
• Who uses them: UK private hospitals, independent specialists, diagnostic labs, and insurers
• Submission route: Claims are submitted electronically to insurer portals, often via a practice management system, with the CCSD code, diagnosis code, and consultant reference included
• Fee schedules: Insurers publish their own fee schedules based on CCSD codes, and these are updated periodically, so practitioners should not assume consistency between insurers
• Pre-authorisation: Complex procedures and specialist tests, including molecular PLA codes, typically require prior approval before the service is delivered

The CQC’s regulatory framework for private healthcare also intersects with billing compliance, since accurate clinical coding underpins the audit and governance requirements for regulated providers. Understanding how CCSD codes fit into that framework matters for any practice offering specialist diagnostics.

Streamline your CCSD code billing with Pabau

Pabau’s claims management tools help UK private practices submit CCSD-coded claims accurately the first time. Reduce manual lookup errors, manage insurer submissions in one place, and keep your billing records audit-ready.

Book a demo

Where to find CCSD codes

Several resources are available for CCSD code lookup, depending on whether you need the official schedule, an insurer-specific fee table, or a clinical workflow tool. The resources coders and billing staff use most often include the following.

Practices using a practice management system with integrated billing can cut lookup friction significantly. Features that save private practices time typically include contextual code surfacing, which presents relevant CCSD codes at the point of care rather than requiring a separate lookup step. For specialist codes like 0186U, that integration reduces the risk of wrong-code submission and supports accurate claim documentation from the outset.

Related PLA and laboratory billing codes

PLA codes are numbered sequentially as new proprietary tests are approved. 0186U sits within the Navigator red cell antigen genotyping series from Grifols, where each code covers a different blood group system or gene. Choosing the right one depends on exactly which gene and antigen were tested.

Reporting 81479 when a specific PLA code exists is an audit risk. Payers expect the most specific applicable code – submitting an unlisted code for a proprietary test that has a defined PLA code, such as CCSD code 0186U, is a common reason for rejection and post-payment audit flags. GDPR compliance for UK private practices also depends on accurate clinical records, which includes billing codes that reflect the tests actually performed.

How Pabau supports CCSD code billing

Pabau is a practice management platform built for UK private healthcare and aesthetics practices. Its billing module is designed around the workflows UK private practices actually use, including CCSD code management and insurer claim submission.

For practices billing specialist investigation codes like CCSD code 0186U, Pabau helps at three points in the workflow.

• Code lookup at point of care: CCSD codes can be attached to treatment records and invoices inside Pabau without switching to a separate reference tool, reducing transposition errors on specialist codes
• Diagnosis code pairing: Billing staff can link ICD-10 diagnosis codes to procedures within the same record, so the claim carries the correct diagnosis pointers before submission
• Insurer claim workflows: Pabau supports claim submission workflows compatible with major UK private insurers, helping practices send CCSD-coded claims to Bupa, AXA Health, and Aviva without re-entering data across portals

For practices managing private-NHS interface pathways alongside wholly private investigation workstreams, a single system for both clinical records and billing cuts the documentation burden considerably. Pabau’s claims management software is well rated by UK and international private practices on Capterra, with users citing ease of CCSD and billing code management. Its GDPR compliance features also help ensure billing documentation for specialist tests meets ICO requirements for data retention and record accuracy.

Pabau’s clinical records module ties billing directly to the patient record, so the pathology report supporting a 0186U claim stays linked to the invoice and insurer submission. That matters during post-payment audits or when an insurer queries a specialist laboratory claim. Keeping client records accurate and current is a core compliance requirement for any UK private practice submitting specialist investigation claims.

Conclusion

CCSD code 0186U covers a precise, single-gene laboratory test: FUT2 exon 2 sequencing to determine H blood group and secretor status. Getting the billing right means confirming payer coverage before the test is done, pairing the claim with diagnosis codes that establish medical necessity, and documenting why genotyping was needed rather than assuming coverage from the descriptor alone.

For UK private practices handling specialist investigation billing alongside a full patient caseload, a system that surfaces CCSD codes in context and supports direct insurer submission removes the manual steps where errors creep in. To see how Pabau handles CCSD code billing from record to claim, book a demo with the team.

Continue your research

Need a complete guide to Bupa CCSD codes and fee schedules? Bupa CCSD codes for UK private practice covers the full CCSD schedule used by Bupa for private healthcare billing.

Billing for other Bupa procedures and want the fee schedule? Bupa procedure codes and fee schedule guide breaks down reimbursement rates and submission requirements for UK private practices.

Considering the move from the NHS to private practice? Leaving the NHS for private practice covers the billing, compliance, and operational steps involved in setting up as a private specialist.

Frequently asked questions